Endotis Pharma has announced the formation of a strategic alliance with Catalent Pharma Solutions (a worldwide leader in pharmaceutical technologies and services). The two companies will collaborate ...
No Abstract BioWorld International CorrespondentPARIS - Endotis Pharma, which is developing small-glyco drugs for applications in thrombosis and oncology, has obtained public funding of €4.5 million ...
OSS, The Netherlands, October 30 /PRNewswire/ -- Organon, the human healthcare business unit of Akzo Nobel, today announced that it has signed an exclusive, worldwide license agreement with Endotis ...
Endotis Pharma, a French developer of small-glyco drugs for applications in thrombosis and oncology, has raised EUR 25 million in Series B funding. The Wellcome Trust led the round, and was joined by ...
antithrombotic compounds with an innovative dual mechanism of action. Financial details are not disclosed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback